Acute Exacerbation of Idiopathic Pulmonary Fibrosis Versus Infection

The differential includes infection, acute exacerbation of IPF, heart failure, pulmonary embolism, drug toxicity, and aspiration. Acute exacerbation of IPF is a diagnosis of exclusion, but several features point toward it:

• New bilateral ground-glass opacities on a background of definite UIP, without consolidation or effusion.
• Low procalcitonin and absence of purulent sputum suggest bacterial infection is less likely, though it does not exclude viral infection.
• Normal BNP and normal echocardiogram make cardiogenic edema unlikely.
• No JVD or edema argues against volume overload.

Infection can trigger an acute exacerbation, so the two are not mutually exclusive. A conservative approach treats infection while also considering acute exacerbation. The absence of an alternative cause after appropriate evaluation supports the diagnosis.

Initial management should be supportive and diagnostic at the same time:

• Oxygen to target SpO2 88–92% to avoid oxygen toxicity and worsening hypercapnia.
• Empiric broad-spectrum antibiotics until cultures and viral testing return, because bacterial and viral triggers are common and cannot be excluded at presentation.
• Corticosteroids: high-dose IV methylprednisolone (e.g., 500–1000 mg/day for 3 days) is often used, but evidence is weak and does not convincingly improve survival. It is reasonable in a patient with acute exacerbation after infection is addressed, but it should not delay antibiotics or supportive care.
• Continue pirfenidone unless there is a specific contraindication; do not stop chronically prescribed antifibrotic therapy abruptly.
• Avoid fluid overload and treat with diuretics only if there is evidence of volume excess.
• Refer for lung transplant evaluation if he is a candidate, because acute exacerbation is a high-risk event.

There is no routine role for anticoagulation or high-dose immunosuppression beyond corticosteroids.

This conversation should happen early, before the patient tires. Acute exacerbation of IPF carries a high short-term mortality, often 50–80% in hospitalized patients, and outcomes after mechanical ventilation are particularly poor. Intubation is not absolutely futile, but it is unlikely to be a bridge to recovery unless the patient is a transplant candidate or has a reversible trigger that can be treated quickly.

A reasonable approach:

• Explain that the underlying fibrosis is progressive and that this event is superimposed on severe disease.
• Clarify that noninvasive ventilation may be used as a comfort measure or time-limited trial, but invasive ventilation often prolongs dying rather than restoring meaningful survival.
• Ask about values and goals: would he accept a time-limited trial of intubation? Does he want to be considered for transplant?
• Involve palliative care for symptom management and family support.
• Reassess frequently; goals can change as the clinical course evolves.

The judgment call is to avoid both premature nihilism and uncontrolled escalation of care that the patient would not want.